decidual stromal cells
Cell therapyexperimental
Clinical trial activity
9 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT02172937)
Timeline
Indications
Studied for
- Acute Lung Injury · Phase 1/Phase 2
- Graft vs Host Disease · Phase 2
- Hematopoietic Stem Cell Transplantation · Phase 2
- Hemorrhage · Phase 2
- Inflammation · Phase 1/Phase 2
- Movement Disorders · Phase 1
- Myeloproliferative Disorders · Phase 2
- Neurodegenerative Diseases · Phase 1
- Parkinson Disease · Phase 1
- Stem Cell Transplantation · Phase 2
- Stromal Cells · Phase 2
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- decidual stromal cells
- placenta derived decidual stromal cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07232147 | Phase 1 | Dec 1, 2025 | Government of China |
| NCT05132166 | Phase 2 | Nov 30, 2021 | University of Toronto |
| NCT04926194 | Phase 2 | Mar 11, 2021 | University of Toronto |
| NCT04451291 | N/A | Aug 24, 2020 | University of Oslo, University of Toronto |
| NCT02172924 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2017 | Karolinska Institute |
| NCT02174536 | Phase 2 | Mar 1, 2014 | Karolinska Institute |
| NCT02175303 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2013 | Karolinska Institute |
| NCT02172963 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2011 | Karolinska Institute |
| NCT02172937 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2011 | Karolinska Institute |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Karolinska Institute | Academic/Hospital | 5 | 5 | 1 | 2011 |
| University of Toronto | Academic/Hospital | 3 | 3 | 2 | 2020 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
| University of Oslo | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1